Media Pack
News

Current Edition

Volume 7 Issue 2

Upcoming Events

 

Advertisement

 
 
 
 
How Has the COVID-19 Pandemic Amplified the Importance of the IVD Industry?
Volume 3 Issue 3

How Has the COVID-19 Pandemic Amplified the Importance of the IVD Industry?

As the world is still coming to grips with the COVID-19 pandemic, the role of IVD in detecting, and thus helping in finding an appropriate immune response to, the nov...
10 December 2020 Volume 3 Issue 3
Continue Reading →
The Benefits of Outsourcing for Early-stage Drug Development
Volume 3 Issue 3

The Benefits of Outsourcing for Early-stage Drug Development

The investment drug companies are making into producing biosimilars has never been greater. This major push is driven by the faster time to market of a biosimilar pro...
10 December 2020 Volume 3 Issue 3
Continue Reading →
New Wave of R&D Points the Way to Tackling the Oldest Enemy
Volume 3 Issue 3

New Wave of R&D Points the Way to Tackling the Oldest Enemy

The COVID-19 pandemic has forced businesses of every kind to adjust and pivot, demolishing all manner of received wisdom along the way. The changing environment has a...
10 December 2020 Volume 3 Issue 3
Continue Reading →
Base Editing, the Story So Far
Volume 3 Issue 3

Base Editing, the Story So Far

Gene editing technologies have been evolving since CRISPR was first commercialised in early 2012. The recent emergence of CRISPR base editing platforms has attracted ...
10 December 2020 Volume 3 Issue 3
Continue Reading →
Re-modelling Drug Delivery Services for High-viscosity Formulations
Volume 3 Issue 3

Re-modelling Drug Delivery Services for High-viscosity Formulations

Biologic formulations for subcutaneous delivery allow patients to self-administer their treatment and reduce the need for them to consult hospital-based healthcare pr...
10 December 2020 Volume 3 Issue 3
Continue Reading →
A Global Approach to Nitrosamine Impurity Testing for Drug Products
Volume 3 Issue 3

A Global Approach to Nitrosamine Impurity Testing for Drug Products

Manufacturers and regulatory authorities around the world are now aware of the potential threat posed by nitrosamine impurities in API/DP. By taking a global, collabo...
10 December 2020 Volume 3 Issue 3 Nitrosamine | SGS
Continue Reading →
Transforming the Healthcare Landscape with Synthetic Biology and Living Medicines
Volume 3 Issue 3

Transforming the Healthcare Landscape with Synthetic Biology and Living Medicines

There is a well-recognised global need for therapeutic options for diseases that are deemed difficult to treat or are currently untreatable. The emergence of syntheti...
10 December 2020 Volume 3 Issue 3
Continue Reading →
Helping Labs Operate at Peak Efficiency to Foster Innovation
Volume 3 Issue 3

Helping Labs Operate at Peak Efficiency to Foster Innovation

Science, as Vannevar Bush wrote, is an endless frontier. Bush, the founder of Raytheon and Director of the Office of Science and Development at its inception in 1941,...
10 December 2020 Volume 3 Issue 3
Continue Reading →
The Solution to Improve Profitability in Pharmaceutical Development; How to Increase Pre-clinical Productivity and Success Rates in Clinical Trials
Volume 3 Issue 3

The Solution to Improve Profitability in Pharmaceutical Development; How to Increase Pre-clinical Productivity and Success Rates in Clinical Trials

The limited availability and usage of pre-clinical laboratory instruments which provide biologically relevant data has resulted in unnecessarily high failure rates of...
10 December 2020 Volume 3 Issue 3
Continue Reading →
Tightly Coupling the Laboratory to the Pharmaceutical Manufacturing Process is Essential to Success
Volume 3 Issue 3

Tightly Coupling the Laboratory to the Pharmaceutical Manufacturing Process is Essential to Success

All manufacturing flows – whether making cars, food products, medical devices, or pharmaceuticals – take raw materials, and through a series of manufacturing processe...
10 December 2020 Volume 3 Issue 3
Continue Reading →
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte